Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not yet recruiting Phase 1 Interventional Accepts healthy volunteers

A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1010 in Healthy Children

ClinicalTrials.gov ID: NCT07870330

Public ClinicalTrials.gov record NCT07870330. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 14, 2026, 8:16 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1, Dose-escalation, Blinded Study to Evaluate Safety, Reactogenicity, and Immunogenicity of mRNA-1010 in Healthy Children (9 to <18 Years of Age)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate safety, reactogenicity, and immunogenicity of mRNA-1010 in healthy children (9 to \<18 years of age).

Study identification

NCT ID
NCT07870330
Recruitment status
Not yet recruiting
Study type
Interventional
Phase
Phase 1
Lead sponsor
ModernaTX, Inc.
Industry
Enrollment
96 participants

Conditions and interventions

Interventions

Biological

Eligibility (public fields only)

Age range
9 Years to 17 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 7, 2026 (Estimated)
Primary completion
Dec 7, 2027 (Estimated)
Completion
Dec 7, 2027 (Estimated)
Last update posted
Oct 13, 2026

2026 – 2027

United States locations

U.S. sites
6
U.S. states
6
U.S. cities
6
Facility City State ZIP Site status
Paradigm Clinical Research Centers, LLC Modesto California 95355 —
Paradigm Clinical Research Centers, LLC Aurora Colorado 80012 —
Clinical Research Institute, Inc Minneapolis Minnesota 55402 —
Senders Pediatrics South Euclid Ohio 44121 —
West Houston Clinical Research Service Houston Texas 77055 —
Clinical Research Partners, LLC. Richmond Virginia 23226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07870330, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 13, 2026 · Synced Oct 14, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT07870330 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →